期刊文献+

玻璃体腔内注射曲安奈德后的眼压变化 被引量:5

Changes ofintraocular pressure after intravitreous injection with triamcinolone acetonide
下载PDF
导出
摘要 目的观察玻璃体腔内注射曲安奈德(TA)后的眼压变化。方法回顾性收集我院接受TA玻璃体腔注射治疗黄斑水肿的138例(138只眼)患者的临床资料。治疗前1d测量眼压,每眼测3次,取平均值。所有患者均接受4mgTA常规玻璃体腔内注射。治疗后1周、2周、1个月同样方法测量眼压,以后每个月复查1次,随诊半年。以眼压≥21mmHg为眼压升高。对比分析治疗前后眼压的变化。结果治疗后有22只眼眼压升高,占15.94%,其中92.8%的患者高眼压出现在3个月内,治疗后5个月有21只眼恢复到基础水平,有1只眼行小梁切除术,随访期峰值平均眼压(16.39±4.37)mmHg,注药前平均眼压(14.77±2.80)mmHg,对所有数据进行t检验(P=0.004,P<0.01)有显著差异,按照性别、年龄因素分组分析,采用方差分析,各组之间无显著统计学意义。结论 TA玻璃体腔内注射后眼压升高较常见,眼压升高多发生于3个月内,注射后至少随诊观察6个月。大多数眼压高的患者眼压能控制到基础水平,极少数患者引起激素性青光眼需手术治疗。 Objective To observe the change ofintraocular pressure(IOP)after intravitreous injection with triamcinolone acetonide(TA) AND their affected factors.Methods The clinical data of 138 patients(138eyes) who had undergone intravitreous injection with TA were retrospectively analyzed.One day before the treatment.All of the patients underwent intravitreous injection with 4 mg TA.IOP was measured one day,3day,one week,2weeks,and one month after the treatment in the same way,respectively,and later was measured once every month.The follow-up period was 6months.The elevation of IOP would be defined as the pressure of 21 mm Hg or higher.The changes of IOP in patients before and after the treatment,and with ages and sex were analyzed.Results 22 patients(15.94%) had elevation of IOP after treatment,out of whom 92.8% had the elevation within 3months after the injection,5months later,the IOP of 21patients decreased to the basic level,one patient was treated trabeculectomy.During the follow-up period,the mean maximum IOP was(16.39 ±4.37) mm Hg,the mean maximum IOP before treatment was(14.77 ± 2.80) mm Hg,and the difference between the groups was significant(P = 0.004,P 0.01).According to the result of analysis of age and sex,no difference between the groups was significant significant.Conclusion Elevation of IOP after intravitreous injection with TA is common,the elevation of IOP was approximately within 3months after injection,the follow-up period was at least 6 months,most of the IOP can be controlled to the basic level,only a few of patients with corticosteroid-induced glaucoma need surgery.
出处 《临床眼科杂志》 2010年第4期331-333,共3页 Journal of Clinical Ophthalmology
关键词 曲安奈德 眼内压 玻璃体腔内注射 并发症 Triamcinolone acetonide Intraocular pressure Intravitreous injection
  • 相关文献

参考文献10

  • 1Jonas JB,Kreissing I,Degenring R.Introcular pressure after intravitreal injection of triamcinolone acetonide.Br J Ophthalmol,2003,87:24-27. 被引量:1
  • 2Jonas JB,Kreissing I,Degenring R.Secondery chronic open-angle glaucoma after intravitreal triamcinolone acetonide.Br J Ophthalmol,2003,121:729-730. 被引量:1
  • 3王景昭.黄斑水肿的药物和手术治疗[J].中华眼底病杂志,2004,20(5):316-319. 被引量:26
  • 4Singh IP Ahmad SI,Yeh D,et al.Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection.Am J Ophthalmo1,2004,138:286-287. 被引量:1
  • 5Smithen LM,Ober MD,Maranan L,et al.Intravitreal triamcinolone acetonide and intraocular pressure.Am J Ophthalmol,2004,138:740-743. 被引量:1
  • 6Chan CK,Fan DS,Chan WM.et al Ocular-hypertensive response and corneal endothelilm changes after intravitreal triamcinolone acetonide injection in Chinese subjects:a 6-months follow-up.Study Eye,2005,19:625-630. 被引量:1
  • 7Jonas JB.Introcular availability of triamcinolone acetonide after intravitreal injection.Am J Ophthalmo1,2004,137:560-562. 被引量:1
  • 8钱彤,黎晓新.玻璃体腔注射曲安奈德后的眼压改变[J].中华眼底病杂志,2007,23(2):115-117. 被引量:35
  • 9Jonas JB,Degenring R,Kreissing I.Introcular pressure elevation after intravitreal triamcinolone acetonide injection.Ophthalmology,2005,112:593-598. 被引量:1
  • 10王丽丽,宋虎平,刘蓓.玻璃体腔注射曲安奈德治疗黄斑水肿的眼压变化(英文)[J].国际眼科杂志,2007,7(5):1233-1236. 被引量:11

二级参考文献43

  • 1王景昭.黄斑水肿的药物和手术治疗[J].中华眼底病杂志,2004,20(5):316-319. 被引量:26
  • 2张雁冰,成霄黎,董静.二次玻璃体腔注射曲安奈德治疗糖尿病性黄斑水肿[J].国际眼科杂志,2005,5(6):1207-1210. 被引量:18
  • 3Antcliff RJ,Spalton DJ,Stanford MR,et al. Intravitreal triamcinolone for uveitic cystoid macular edema:an optical coherence tomography study. Ophthalmology,2001,108: 765-772. 被引量:1
  • 4LashayAR, Rahimi A,Chams H,et al. Evaluation of the effect of acetzolamide on cystoid macular edema in patients with Behcet′s disease. Eye,2003,17:762-766. 被引量:1
  • 5Kobayashi H,Kobayashi K,Okinami S. Randomized clinical trial of topical betaxolol for persistent macular edema after vitrectomy and epiretinal membrane removal. Am J Ophthalmol, 2003,136:244-251. 被引量:1
  • 6Campochiaro PA,The C99-PKC412-003 Study Group. Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412. Invest Ophthalmol Vis Sci, 2004,45: 922-931. 被引量:1
  • 7Danis RP,Bingaman DP,Yang Y,et al. Inhibition of preretinal and optic nerve head neovascularization in pig by intravitreal triamcinolone acetonide. Ophthalmol,1996,103: 2099-2104. 被引量:1
  • 8Danis RP,Ciulla TA,Partt LM,et al.Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.Retina,2000,20: 244-250. 被引量:1
  • 9Jonas JB,Kreissig I,Kamppeter B,et al. Intrvitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases. Ophthalmology, 2004,101: 113-120. 被引量:1
  • 10Beer PM,Bakri ST,Singh RT,et al. Intraocular concentration and pharmacokinetics of tramcinolone acetonide after a single intravitreal injection.Ophthalmology, 2003, 110: 681-686. 被引量:1

共引文献60

同被引文献30

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部